Trial Profile
A Phase 1, Open-Label, Randomized, 2×2 Crossover Study of Pharmacodynamics Comparing the Impact of Tablet Size and Fasting Status With an Oral Human Influenza A/California/04/2009 (H1N1) HA Adenoviral-Vector Based Vaccine and dsRNA Adjuvant
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Jun 2018
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacokinetics
- Sponsors Vaxart
- 29 May 2018 Status changed from active, no longer recruiting to completed.
- 24 Apr 2017 New trial record